Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Very Low-dose Total Body Irradiation in Combination With Total Lymphoid Irradiation and Anti-Thymocyte Globulin to Improve Donor Engraftment in Patients Undergoing Non-Myeloablative Hematopoietic Cell Transplantation

NCT03734601 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03734601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03734601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Very Low-dose Total Body Irradiation in Combination With Total Lymphoid Irradiation and Anti-Thymocyte Globulin to Improve Donor Engraftment in Patients Undergoing Non-Myeloablative Hematopoietic Cell Transplantation
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
November 5, 2018
Completion date
November 17, 2020
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, b-cell lymphoma, chronic lymphocytic leukemia, chronic myelomonocytic leukemia, hodgkin lymphoma, myelodysplastic syndromes, myeloproliferative disorder, non hodgkin lymphoma, t-cell lymphoma